WILLIAM J FEBBO
CIK 1413987 · CEO · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$25.20M
Companies
7
Total Filings
67
Lifetime Open-Market Net
-$11.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MYO | Director | 123,704 | $0.95 | $118.1K | $0 | 2 | 2026-06-26 |
| OPRX | CEO | 600,852 | $6.34 | $3.81M | -$11.56M | 32 | 2025-02-20 |
| Augmedix, Inc. (AUGX) Delisted | Director | 162,583 | $2.35 | $382.1K | $59.7K | 6 | 2024-07-15 |
| MODD | Director | 3,054 | $2.34 | $7.1K | $0 | 8 | 2023-07-05 |
| LFMDP | Director | 450,000 | $23.46 | $10.56M | $0 | 1 | 2023-06-22 |
| Merriman Holdings, Inc (MERR) Delisted | Director | — | — | — | $0 | 1 | 2008-05-06 |
| MEM | Director | 259,271 | $41.29 | $10.71M | $15.0K | 1 | 2007-11-26 |
Recent Filings · Page 2 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-17 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | MODD | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-06-22 | LFMDP | Grant (A) | +75,000 | $0 | EDGAR |
| 2023-06-16 | Augmedix, Inc. (AUGX) Delisted | Exer (M) | +52,632 | $0 | EDGAR |
| 2023-04-20 | OPRX | Grant (A) | — | $0 | EDGAR |
| 2023-04-03 | MODD | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-01-31 | OPRX | Exer (M) | +9,628 | $0 | EDGAR |
| 2023-01-03 | MODD | Grant (A) | +2,500 | $0 | EDGAR |
| 2022-10-03 | MODD | Grant (A) | +2,500 | $0 | EDGAR |
| 2022-08-23 | OPRX | Buy (P) | +16,100 | $251.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.